v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Series C Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at the beginning at Dec. 31, 2024 $ 15,507,000              
Balance at the beginning (in shares) at Dec. 31, 2024 973,000              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (131,000)              
Series C convertible preferred stock conversion $ (1,754,000)              
Balance at the end at Jun. 30, 2025 $ 13,753,000              
Balance at the end (in shares) at Jun. 30, 2025 842,000              
Balance at the beginning at Dec. 31, 2024   $ 1,328,000 $ 1,344,720,000   $ (79,000) $ (1,443,499,000) $ 3,043,000 $ (94,487,000)
Balance at the beginning (in shares) at Dec. 31, 2024   1,328,622,000            
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 4,000 1,750,000         1,754,000
Series C convertible preferred stock conversion (in shares)   3,263,000            
Issuance of common stock for cash, net   $ 56,000 12,386,000         12,442,000
Issuance of common stock for cash, net (in shares)   56,138,000            
Warrants exercised for cash     23,000         23,000
Warrants exercised for cash (in shares)   104,000            
Issuance of common stock for conversion of debt and accrued interest   $ 71,000 18,672,000         18,743,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   70,484,000            
Stock-based compensation     749,000         749,000
Stock-based compensation (in shares)   150,000            
Warrant modifications     825,000         825,000
Deemed dividend related to warrant modifications     (825,000)         (825,000)
Net loss           (34,721,000)   (34,721,000)
Cumulative translation adjustment             (4,892,000) (4,892,000)
Balance at the end at Jun. 30, 2025   $ 1,459,000 1,378,300,000   (79,000) (1,478,220,000) (1,849,000) (100,389,000)
Balance at the end (in shares) at Jun. 30, 2025   1,458,761,000            
Balance at the beginning at Mar. 31, 2025 $ 14,641,000              
Balance at the beginning (in shares) at Mar. 31, 2025 904,000              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (62,000)              
Series C convertible preferred stock conversion $ (888,000)              
Balance at the end at Jun. 30, 2025 $ 13,753,000              
Balance at the end (in shares) at Jun. 30, 2025 842,000              
Balance at the beginning at Mar. 31, 2025   $ 1,391,000 1,360,652,000   (79,000) (1,462,842,000) 1,399,000 (99,479,000)
Balance at the beginning (in shares) at Mar. 31, 2025   1,391,253,000            
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 2,000 886,000         888,000
Series C convertible preferred stock conversion (in shares)   1,543,000            
Issuance of common stock for cash, net   $ 33,000 7,286,000         7,319,000
Issuance of common stock for cash, net (in shares)   33,391,000            
Warrants exercised for cash     6,000         6,000
Warrants exercised for cash (in shares)   28,000            
Issuance of common stock for conversion of debt and accrued interest   $ 33,000 9,106,000         9,139,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   32,471,000            
Stock-based compensation     364,000         364,000
Stock-based compensation (in shares)   75,000            
Warrant modifications     560,000         560,000
Deemed dividend related to warrant modifications     (560,000)         (560,000)
Net loss           (15,378,000)   (15,378,000)
Cumulative translation adjustment             (3,248,000) (3,248,000)
Balance at the end at Jun. 30, 2025   $ 1,459,000 1,378,300,000   (79,000) (1,478,220,000) (1,849,000) (100,389,000)
Balance at the end (in shares) at Jun. 30, 2025   1,458,761,000            
Balance at the beginning at Dec. 31, 2025 $ 12,710,000              
Balance at the beginning (in shares) at Dec. 31, 2025 784,347              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (146,000)              
Series C convertible preferred stock conversion $ (2,312,000)              
Balance at the end at Jun. 30, 2026 $ 10,398,000              
Balance at the end (in shares) at Jun. 30, 2026 637,614              
Balance at the beginning at Dec. 31, 2025   $ 1,567,000 1,442,830,000 $ (12,000) (79,000) (1,503,661,000) (925,000) $ (60,280,000)
Balance at the beginning (in shares) at Dec. 31, 2025   1,567,433,000            
Balance at the beginning (in shares) at Dec. 31, 2025       (12,000,000)       12,000,000
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 4,000 2,308,000         $ 2,312,000
Series C convertible preferred stock conversion (in shares)   3,668,000            
Issuance of common stock for cash, net   $ 13,000 2,991,000         3,004,000
Issuance of common stock for cash, net (in shares)   12,926,000            
Warrants exercised for cash     20,000         20,000
Warrants exercised for cash (in shares)   79,000            
Cashless warrant exercise (in shares)   140,000            
Issuance of common stock for conversion of debt and accrued interest   $ 96,000 20,664,000         20,760,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   96,259,000            
Issuance of common stock as debt offering cost   $ 1,000 149,000         150,000
Issuance of common stock as debt offering cost (in shares)   833,000            
Stock-based compensation     469,000         469,000
Warrant modifications     664,000         664,000
Deemed dividend related to warrant modifications     (662,000)         (662,000)
Net loss           (12,290,000)   (12,290,000)
Cumulative translation adjustment             679,000 679,000
Balance at the end at Jun. 30, 2026   $ 1,681,000 1,469,433,000 $ (12,000) (79,000) (1,515,951,000) (246,000) $ (45,174,000)
Balance at the end (in shares) at Jun. 30, 2026   1,681,338,000            
Balance at the end (in shares) at Jun. 30, 2026       (12,000,000)       12,000,000
Balance at the beginning at Mar. 31, 2026 $ 12,484,000              
Balance at the beginning (in shares) at Mar. 31, 2026 767,000              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) 129,000              
Series C convertible preferred stock conversion $ (2,086,000)              
Balance at the end at Jun. 30, 2026 $ 10,398,000              
Balance at the end (in shares) at Jun. 30, 2026 637,614              
Balance at the beginning at Mar. 31, 2026   $ 1,619,000 1,455,087,000 $ (12,000) (79,000) (1,506,730,000) (429,000) $ (50,544,000)
Balance at the beginning (in shares) at Mar. 31, 2026   1,618,857,000            
Balance at the beginning (in shares) at Mar. 31, 2026       (12,000,000)        
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 3,000 2,083,000         2,086,000
Series C convertible preferred stock conversion (in shares)   3,228,000            
Issuance of common stock for cash, net   $ 1,000 103,000         104,000
Issuance of common stock for cash, net (in shares)   538,000            
Warrants exercised for cash     14,000         14,000
Warrants exercised for cash (in shares)   54,000            
Issuance of common stock for conversion of debt and accrued interest   $ 57,000 11,814,000         11,871,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   57,828,000            
Issuance of common stock as debt offering cost   $ 1,000 149,000         150,000
Issuance of common stock as debt offering cost (in shares)   833,000            
Stock-based compensation     181,000         181,000
Warrant modifications     334,000         334,000
Deemed dividend related to warrant modifications     (332,000)         (332,000)
Net loss           (9,221,000)   (9,221,000)
Cumulative translation adjustment             183,000 183,000
Balance at the end at Jun. 30, 2026   $ 1,681,000 $ 1,469,433,000 $ (12,000) $ (79,000) $ (1,515,951,000) $ (246,000) $ (45,174,000)
Balance at the end (in shares) at Jun. 30, 2026   1,681,338,000            
Balance at the end (in shares) at Jun. 30, 2026       (12,000,000)       12,000,000